Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $2.17 Million - $3.39 Million
-10,000 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $2.79 Million - $3.53 Million
10,000 New
10,000 $3.01 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track Michael Burry's Portfolio

Track Michael Burry Portfolio

Follow Michael Burry (Scion Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scion Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scion Asset Management, LLC and Michael Burry with notifications on news.